Explore All 631 Divestiture Chemicals Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | August 23, 2021 |
| Target | Deltech - Monomers Polymers & European Businesses |
| Sector | Chemicals |
| Buyer(s) | SK Capital Partners |
| Sellers(s) | Deltech |
| Deal Type | Divestiture |
FILTER BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2007 |
| PE ASSETS | 4.9B USD |
| Size | Large |
| Type | Sector Agnostic |
SK Capital Partners is a private investor in mature and middle-market companies located throughout North America. SK Capital focuses on companies with opportunities for substantial business improvement and strong growth prospects. The Firm looks to invest $100 to $200 million of equity in transactions valued up to $500 million. Prospective businesses typically generate $50 to $500 million in revenues and at least $100 million in EBITDA. Areas of interest include specialty materials, chemicals and healthcare. The Firm will consider a variety of transaction situations, including buyouts, recapitalizations, growth equity financings, and corporate carve-outs. SK Capital Partners was spun out of Arsenal Capital Partners and became independent in 2007. SK Capital Partners is based in New York City.
| Deal Context for Buyer | # |
|---|---|
| Overall | 32 of 45 |
| Sector: Chemicals | 20 of 21 |
| Type: Divestiture | 14 of 17 |
| State: Louisiana | 1 of 1 |
| Country: United States | 21 of 28 |
| Year: 2021 | 7 of 7 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-06-21 |
Niacet
Niagara Falls, New York, United States Niacet is a producer of specialty ingredients for food, feed, and pharmaceutical applications and the global leader in propionates and acetates. The Company’s propionates function as preservatives in baked goods and animal feed, while its acetates serve a wide variety of food and pharmaceutical applications. Niacet was established in 1978 and is based in Niagara Falls, New York. |
Sell | $1.0B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-08-26 |
Wavelength Pharmaceuticals
Petah Tikva, Israel Wavelength Pharmaceuticals is a developer and manufacturer of generic APIs and finished dose forms (“FDF”) with operations primarily located in Israel and supporting functions in the U.S. and India. The Business has a global customer base and a broad array of products that leverage its specialized manufacturing capabilities and core competency in complex chemistries. Wavelength Pharmaceuticals is based in Petah Tikva, Israel. |
Sell | - |
Deltech is a provider in the production of high-performance aromatic monomers and specialized crystal polystyrene. Deltech's portfolio includes vinyl toluene (VT), divinyl benzene (DVB) and para methyl styrene (PMS), in addition to their specialty crystal polystyrene. Deltech was founded in 1988 and is based in Baton Rouge, Louisiana.
| Deal Context for Seller | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Chemicals | 1 of 1 |
| Type: Divestiture | 1 of 1 |
| State: Louisiana | 1 of 1 |
| Country: United States | 1 of 1 |
| Year: 2021 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-10-04 |
StanChem
East Berlin, Connecticut, United States StanChem is a chemical manufacturer specializing in the research, development, manufacture, and marketing of emulsion polymers, adhesives, and specialty coatings for a variety of applications including paints, paper and packaging, building products, textiles, and non-wovens. In addition to its specialty polymers business, the company produces and markets the well-known Albi line of flame retardant products. StanChem was founded in 1968 and based in East Berlin, Connecticut. |
Buy | - |
